Page last updated: 2024-11-05

thiabendazole and Sarcoidosis, Pulmonary

thiabendazole has been researched along with Sarcoidosis, Pulmonary in 1 studies

Tresaderm: dermatologic soln containing dexamethasone, thiabendazole & neomycin sulfate

Sarcoidosis, Pulmonary: Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Almasidou, D1
Maniatis, M1
Vassiou, K1
Damani, E1
Vakalis, N1
Fesoulidis, I1
Gourgoulianis, KI1

Other Studies

1 other study available for thiabendazole and Sarcoidosis, Pulmonary

ArticleYear
Strongyloides hyperinfection in a patient with sarcoidosis.
    Respirology (Carlton, Vic.), 2003, Volume: 8, Issue:1

    Topics: Animals; Female; Follow-Up Studies; Humans; Middle Aged; Risk Assessment; Sarcoidosis, Pulmonary; Se

2003